Carolyn Beaumont is an Australian general practitioner and tobacco harm reduction educator. She is a staunch advocate for the rights of adult smokers to access nicotine in the safest way possible.

Beaumont founded the Australian vape prescription service MedicalNicotine in 2020. With Australia’s unique stance on banning overseas personal importation of vapes and requiring a script for pharmacy-only vapes, she has a deep understanding of the many issues and limitations this brings. While supporting a regulated consumer model for adult vaping, she is pragmatic about Australia’s current stringent regulatory environment and aims to make adult vape script access as affordable and easy as possible.

In 2023, Beaumont expanded the concept of MedicalNicotine vape scripts to the more holistic SmokerHealth clinic. SmokerHealth has one goal: to reduce smoking-related death and disease. As well as vape scripts, it provides preventive care specifically for smokers. Lung cancer screening, cardiac and respiratory disease are managed and are government funded where possible.

Since 2020, Beaumont has developed a media profile in tobacco harm reduction, being one of Australia’s few vape-prescribing doctors, and loves to engage and educate about harm reduction and youth vaping issues. She has appeared in national media and on TV, co-authored articles with Colin Mendelsohn, presented to secondary schools about black market vapes, and is a regular contributor to global tobacco harm reduction forums. Current projects include vape education for Australian pharmacists and building her SmokerHealth business as a general practitioner.

Beaumont has general practitioner fellowship and holds a doctor of medicine degree, a postgraduate diploma in child health and teaching qualifications, was the highest-ranking student in her Bachelor of Medical Science degree program, and received first-class honors in her Bachelor of Music degree program. She had a previous “second life” as a pianist and teacher before embarking on medical studies in her late 30s.